ClinicalTrialsFinder

Recurrent B-Cell Non-Hodgkin Lymphoma Clinical Trials in Orland Park, Illinois

1 recruitingOrland Park, Illinois

Showing 1–1 of 1 trials

Recruiting
Phase 1

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

Recurrent B-Cell Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma+3 more
National Cancer Institute (NCI)32 enrolled9 locationsNCT05272384